adenocarcinoma

Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate.

Our findings suggest that the diagnosis of ductal and acinar adenocarcinoma of the prostate can be based on pathological and immunohistochemical examinations.

Transdural Metastasis from Adenocarcinoma of the Prostate mimicking SDH: Case Report.

The study group comprised 5,295 men with localized adenocarcinoma of the prostate.

Final pathology was consistent with metastatic adenocarcinoma of the prostate.

This specimen was reported as an adenocarcinoma of the prostate.

The role of prostate specific antigen as a tumor marker in men with advanced adenocarcinoma of the prostate.

4) In the patient reported here, prostate carcinoma was classified as localized adenocarcinoma of the prostate on histopathology and was clinical stage T1c with a Gleason score 2+3.

Unsuspected adenocarcinoma of the prostate in patients undergooing cystoprostatectomy for other causes: incidence, histology and morphometric observations.

Baxter focused on patients with invasive, nonmetastatic, adenocarcinoma of the prostate who entered the registry during 1973-1994, a total of more than 85,000 men.

Autopsy studies have shown that a third of adults have cancer cells in their thyroid; up to 40 percent of women in their 40s have ductal carcinoma in situ in their breasts; and half of men in their 60s have adenocarcinoma of the prostate.

Prostate-specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate [Review].

The study is being conducted at the University College London Hospitals NHS Trust (UCLH) to evaluate hemiablation therapy using HIFU in the treatment of localized adenocarcinoma of the prostate (prostate cancer).

Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate.

Dramatic rise in prostatic specific antigen after androgen replacement in hypogonadal men with occult adenocarcinoma of the prostate.